Iqvia share price today
(NASDAQ: IQV)

Name: Iqvia Share Price Today (NASDAQ: IQV) - Iqvia Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Iqvia share price is $205.42 & ₹17,748.29 as on 23 Jan 2025, 2.30 'hrs' IST

$205.42

▲

-0.27

(-0.13%)

Market is closed - opens 8 PM, 23 Jan 2025

View live Iqvia share price in Dollar and Rupees. Guide to invest in Iqvia stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Iqvia, along with analyst recommendations, forecasts, and comprehensive financials.

Iqvia share price movements

Today's Low: $203.63
Today's High: $207.06
$205.42
0.87%
Downside
Day's Volatility :1.66%
Upside
0.79%
52 Weeks Low: $187.62
52 Weeks High: $261.73
$205.42
8.67%
Downside
52 Weeks Volatility :28.32%
Upside
21.51%

Iqvia Returns

Period	Iqvia Holdings Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-2.97%	-5.5%	0.0%
6 Months	-11.57%	-4.3%	0.0%
1 Year	-3.5%	1.6%	0.0%
3 Years	-15.71%	9.8%	-11.0%

Iqvia Key Statistics

in dollars & INR

Previous Close	$205.69
Open	$205.51
Today's High	$207.06
Today's Low	$203.63
Market Capitalization	$37.3B
Today's Volume	$2.2M
52 Week High	$261.73
52 Week Low	$187.62
Revenue TTM	$15.3B
EBITDA	$2.8B
Earnings Per Share (EPS)	$7.61
PE Ratio	26.99
Profit Margin	9.17%
Quarterly Earnings Growth YOY	-0.05%
Return On Equity TTM	22.0%

How to invest in Iqvia Stock (IQV) from India?

It is very easy for Indian residents to invest directly in Iqvia from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Iqvia stock in both Indian Rupees (INR) and US Dollars (USD). Search for Iqvia or IQV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Iqvia or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Iqvia shares which would translate to 0.004 fractional shares of Iqvia as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Iqvia, in just a few clicks!

Returns in Iqvia for Indian investors in Rupees

Investment Value

₹1,00,000

Iqvia investment value today

Current value as on today

₹1,00,442

Returns

₹442

(+0.44%)

Returns from Iqvia Stock

₹3,504 (-3.5%)

Dollar Returns

₹3,946 (+3.95%)

Indian investors sentiment towards Iqvia

145%

Period: Oct 24, 2024 to Jan 22, 2025. Change in 30 Days versus previous period

Search volume for Iqvia on INDmoney from India has grown in the last 30 days as on Jan 23, 2025. 145% more investors are searching Iqvia in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Iqvia

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	1487	-9.03	0.07%
Nippon India US Equity Opportunities Fund Direct Growth	17927	-6267.82	4.31%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	275	0.00	0.29%

Global Institutional Holdings in Iqvia

Vanguard Group Inc
11.03%
BlackRock Inc
8.36%
Harris Associates L.P.
5.61%
State Street Corp
4.28%
Geode Capital Management, LLC
2.26%
AllianceBernstein L.P.
2.14%

Analyst Recommendation on Iqvia

Buy

76%Buy

23%Hold

0%Sell

Based on 26 Wall street analysts offering stock ratings for Iqvia(by analysts ranked 0 to 5 stars)

Based on 26 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Iqvia

What analysts predicted

Upside of 21.23%

Target:

$249.04

Current:

$205.42

Insights on Iqvia

Price Movement
In the last 7 days, IQV stock has moved up by 3.9%
Increasing Revenue
Iqvia Holdings Inc. has shown positive revenue growth over the last three quarters. Their revenue increased from $3.74 billion to $3.89 billion, reflecting an average growth of 2.0% per quarter.
Decreasing Net Profit
Iqvia Holdings Inc. has experienced a decline in net profit over the last two quarters. The net profit decreased from $363.0 million to $285.0 million, resulting in an average decrease of 21.5% per quarter.
IQV vs A (1 yr)
In the last 1 year, Agilent Technologies Inc. has given 15.9% return, outperforming this stock by 19.7%
IQV vs A (3 yr)
In the last 3 years, Agilent Technologies Inc. has given 11.0% return, outperforming this stock by 25.7%
Price to Sales
Iqvia Holdings Inc. has a Price-to-Sales Ratio of 2.4, meaning that investors are willing to pay $2.4 for every $1 of sales the company makes. In contrast, Agilent Technologies Inc. has a higher Price-to-Sales Ratio of 6.9, indicating that investors value its sales more highly.

Iqvia Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$10.4B	↑ 6.91%
Net Income	$259.0M	↓ 80.21%
Net Profit Margin	2.49%	↓ 10.95%

	FY19	Y/Y Change
Revenue	$11.1B	↑ 6.49%
Net Income	$191.0M	↓ 26.25%
Net Profit Margin	1.72%	↓ 0.77%

	FY20	Y/Y Change
Revenue	$11.4B	↑ 2.44%
Net Income	$279.0M	↑ 46.07%
Net Profit Margin	2.46%	↑ 0.74%

	FY21	Y/Y Change
Revenue	$13.9B	↑ 22.14%
Net Income	$966.0M	↑ 246.24%
Net Profit Margin	6.96%	↑ 4.5%

	FY22	Y/Y Change
Revenue	$14.4B	↑ 3.86%
Net Income	$1.1B	↑ 12.94%
Net Profit Margin	7.57%	↑ 0.61%

	FY23	Y/Y Change
Revenue	$15.0B	↑ 3.98%
Net Income	$1.4B	↑ 24.47%
Net Profit Margin	9.06%	↑ 1.49%

	Q2 FY23	Q/Q Change
Revenue	$3.7B	↑ 2.08%
Net Income	$297.0M	↑ 2.77%
Net Profit Margin	7.97%	↑ 0.06%

	Q3 FY23	Q/Q Change
Revenue	$3.7B	↑ 0.21%
Net Income	$303.0M	↑ 2.02%
Net Profit Margin	8.11%	↑ 0.14%

	Q4 FY23	Q/Q Change
Revenue	$3.9B	↑ 4.63%
Net Income	$469.0M	↑ 54.79%
Net Profit Margin	12.0%	↑ 3.89%

	Q1 FY24	Q/Q Change
Revenue	$3.7B	↓ 4.32%
Net Income	$288.0M	↓ 38.59%
Net Profit Margin	7.7%	↓ 4.3%

	Q2 FY24	Q/Q Change
Revenue	$3.8B	↑ 1.98%
Net Income	$363.0M	↑ 26.04%
Net Profit Margin	9.52%	↑ 1.82%

	Q3 FY24	Q/Q Change
Revenue	$3.9B	↑ 2.15%
Net Income	$285.0M	↓ 21.49%
Net Profit Margin	7.32%	↓ 2.2%

	FY18	Y/Y Change
Profit	$3.7B	↑ 6.63%

	FY19	Y/Y Change
Profit	$3.8B	↑ 3.33%

	FY20	Y/Y Change
Profit	$3.9B	↑ 1.87%

	FY21	Y/Y Change
Profit	$4.6B	↑ 20.26%

	FY22	Y/Y Change
Profit	$5.0B	↑ 8.34%

	FY23	Y/Y Change
Profit	$5.2B	↑ 4.2%

	Q2 FY23	Q/Q Change
Profit	$1.3B	↑ 2.47%

	Q3 FY23	Q/Q Change
Profit	$1.3B	↑ 1.95%

	Q4 FY23	Q/Q Change
Profit	$1.1B	↓ 14.89%

	Q1 FY24	Q/Q Change
Profit	$1.0B	↓ 7.44%

	Q2 FY24	Q/Q Change
Profit	$1.1B	↑ 2.42%

	Q3 FY24	Q/Q Change
Profit	$1.4B	↑ 30.37%

	FY18	Y/Y Change
Operating Cash Flow	$1.3B	↑ 29.28%
Investing Cash Flow	$-810.0M	↓ 31.93%
Financing Cash Flow	$-452.0M	↑ 527.78%

	FY19	Y/Y Change
Operating Cash Flow	$1.4B	↑ 13.0%
Investing Cash Flow	$-1.2B	↑ 46.91%
Financing Cash Flow	$-276.0M	↓ 38.94%

	FY20	Y/Y Change
Operating Cash Flow	$2.0B	↑ 38.25%
Investing Cash Flow	$-796.0M	↓ 33.11%
Financing Cash Flow	$-217.0M	↓ 21.38%

	FY21	Y/Y Change
Operating Cash Flow	$2.9B	↑ 50.18%
Investing Cash Flow	$-2.1B	↑ 164.2%
Financing Cash Flow	$-1.2B	↑ 469.12%

	FY22	Y/Y Change
Operating Cash Flow	$2.3B	↓ 23.18%
Investing Cash Flow	$-2.0B	↓ 4.61%
Financing Cash Flow	$-329.0M	↓ 73.36%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$402.0M	↓ 3.6%
Investing Cash Flow	$-596.0M	↑ 168.47%
Financing Cash Flow	$95.0M	↑ 9.2%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$583.0M	↑ 45.02%
Investing Cash Flow	$-1.4B	↑ 133.39%
Financing Cash Flow	$-144.0M	↓ 251.58%

Iqvia Technicals Summary

Sell

Neutral

Buy

Iqvia is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Iqvia Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Iqvia Holdings Inc.	2.72%	-11.57%	-3.5%	-15.71%	30.71%
Agilent Technologies Inc.	12.12%	13.05%	17.58%	10.48%	76.29%
Idexx Laboratories, Inc.	4.1%	-8.52%	-17.23%	-15.84%	55.27%
Thermo Fisher Scientific, Inc.	8.62%	-3.35%	6.41%	-0.21%	73.61%
Danaher Corp.	5.82%	-9.59%	6.81%	-11.8%	51.48%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Iqvia Holdings Inc.	26.99	26.99	1.09	11.11	0.22	0.05	NA	38.37
Agilent Technologies Inc.	34.45	34.45	2.58	5.57	0.25	0.08	0.0	20.53
Idexx Laboratories, Inc.	41.25	41.25	4.41	10.69	0.59	0.23	NA	19.72
Thermo Fisher Scientific, Inc.	35.93	35.93	2.16	21.69	0.13	0.05	0.0	128.08
Danaher Corp.	46.15	46.15	3.18	7.51	0.08	0.04	0.0	71.03

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Iqvia Holdings Inc.	Buy	$37.3B	30.71%	26.99	9.17%
Agilent Technologies Inc.	Buy	$43.6B	76.29%	34.45	21.75%
Idexx Laboratories, Inc.	Buy	$35.0B	55.27%	41.25	22.53%
Thermo Fisher Scientific, Inc.	Buy	$219.2B	73.61%	35.93	14.48%
Danaher Corp.	Buy	$176.3B	51.48%	46.15	16.39%

About Iqvia

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.

Organization	Iqvia
Employees	88000
CEO	Mr. Ari Bousbib
Industry	Health Services

Management People of Iqvia

Name	Title
Mr. Ari Bousbib	CEO & Chairman
Mr. Ronald E. Bruehlman	Executive VP & CFO
Mr. Eric M. Sherbet J.D.	Executive VP, General Counsel & Secretary
Mr. W. Richard Staub III	President of Research & Development Solutions
Ms. Keriann Cherofsky	Senior VP, Corporate Controller & Chief Accounting Officer
Mr. Jim Berkshire	Executive Vice President of Global Technology & Operations
Dr. Jeffrey A. Spaeder M.D.	Senior VP, Global Chief Medical & Scientific Officer
Kerri Joseph	SVP of Investment Relation & Treasury
Ms. Trudy Stein	Chief Human Resources Officer & Executive VP
Dr. Cynthia L. Verst	President of Design & Delivery Innovation

Important FAQs about investing in Iqvia (IQV) from India :

What is Iqvia share price today?

Iqvia share price today stands at $205.42, Open: $205.51 ; Previous Close: $205.69 ; High: $207.06 ; Low: $203.63 ; 52 Week High: $261.73 ; 52 Week Low: $187.62. The stock opens at $205.51, after a previous close of $205.69. The stock reached a daily high of $207.06 and a low of $203.63, with a 52-week high of $261.73 and a 52-week low of $187.62.

Can Indians buy Iqvia shares?

Yes, Indians can invest in the Iqvia (IQV) from India.

With INDmoney, you can buy Iqvia at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Iqvia at zero transaction cost.

How can I buy Iqvia shares from India?

It is very easy to buy Iqvia from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Iqvia be purchased?

Yes, you can buy fractional shares of Iqvia with INDmoney app.

What are the documents required to start investing in Iqvia stocks?

To start investing in Iqvia, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.